Skip to content
For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement.
AMIRAVOResearch Library
Cycle-length evidence

Larazotide cycle length: what human studies ran

InvestigationalBLimited human data
Short answer: there is no established Larazotide cycle length, and we found no human studies that report one.

Treatment and follow-up in human studies

No human study durations are recorded.

What has not been tested

  • On-and-off schedules or breaks between courses.
  • Repeated courses and long-term exposure beyond the periods listed.
  • Larazotide combined with other compounds, unless a study above says so.

Frequently asked questions

Is there an established Larazotide cycle length?
No. We found no human studies that report a treatment duration for Larazotide.
What is the longest human study of Larazotide?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
Larazotide dosing reference Full research page

References

  1. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial Gastroenterology. 2015
  2. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study Aliment Pharmacol Ther. 2013
  3. A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge Am J Gastroenterol. 2012
  4. The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study Aliment Pharmacol Ther. 2007
  5. Larazotide acetate regulates epithelial tight junctions in vitro and in vivo Peptides. 2012
  6. Larazotide acetate promotes tight junction assembly in epithelial cells Peptides. 2012
  7. Larazotide acetate for treatment of celiac disease: A systematic review and meta-analysis of randomized controlled trials Clin Res Hepatol Gastroenterol. 2022
  8. Viral spike antigen clearance and augmented recovery in children with post-COVID multisystem inflammatory syndrome treated with larazotide Sci Transl Med. 2025
  9. Lack of relationship of AT1001 to zonulin and prehaptoglobin-2: clinical implications Gut. 2021
  10. ClinicalTrials.gov record NCT03569007: Phase 3 study of larazotide acetate for persistent symptoms in celiac disease on a gluten-free diet (terminated) ClinicalTrials.gov. 2026
  11. ClinicalTrials.gov record NCT01396213: Phase 2 dose-ranging study of larazotide acetate in celiac disease ClinicalTrials.gov. 2026
  12. ClinicalTrials.gov record NCT05747534: Phase 2a study of larazotide (AT1001) for long COVID in children and adults ClinicalTrials.gov. 2026
  13. ClinicalTrials.gov record NCT05022303: Phase 2a study of AT1001 for COVID-19 related MIS-C (terminated) ClinicalTrials.gov. 2026
  14. World Anti-Doping Agency Prohibited List 2026 (online version) WADA. 2026
  15. PubChem compound record for larazotide PubChem. 2026